as on January 9, 2026 at 4:01 pm IST
Day's Low
Day's High
0.69%
Downside
4.15%
Upside
52 Week's Low
52 Week's High
55.90%
Downside
38.82%
Upside
as on January 9, 2026 at 4:01 pm IST
Market Cap
₹793.66 Cr
Return on Equity (ROE)
14.34
PE Ratio (TTM)
19.43
Return on capital employed (ROCE)
16.95
Industry PE ratio
42.86
Beta (LTM)
0.76
P/B Ratio
2.81
Dividend Yield
0PEG Ratio
0.26
Quarterly Earnings Growth YOY
943
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
as on January 9, 2026 at 4:01 pm IST
Fredun Pharma in the last 5 years
Lowest (0.00x)
March 28, 2025
Today (19.43x)
January 8, 2026
Industry (42.86x)
January 8, 2026
Highest (25.56x)
November 20, 2025
Today’s Price to Earnings Ratio: 19.43x
Compare market cap, revenue, PE, and other key metrics of Fredun Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 793.66 | 51.56% | 0.00 | 15 | 348 | |
| NA | 777.34 | -8.36% | 0.00 | 47 | 661 | |
| NA | 4,385.58 | -6.39% | 1.88 | -343 | 71 | |
| NA | 744.71 | 0.92% | 0.52 | 250 | 561 | |
| NA | 6,620.43 | 30.67% | 0.59 | 272 | 2,115 |
Get share price movements and forecasts by analysts on Fredun Pharma .
Source: S&P Global Market Intelligence
Search interest for Fredun Pharmaceuticals Ltd Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Fredun Pharma .
Fredun Pharmaceuticals Ltd’s net profit jumped 18.58% since last year same period to ₹6.00Cr in the Q4 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated -56.33% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Fredun Pharmaceuticals Ltd has declared dividend of ₹0.70 per share on 31 May 2025 - translating a dividend yield of 0.05%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
![]()
Foreign Institutions have increased holdings from 0.00% to 0.01% in Sep 2025 quarter
Best in 1 Year
![]()
In the last 1 year, Fredun Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.9% return, outperforming this stock by 120.8%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 48.93% of holdings in Sep 2025 quarter
Price Dip
![]()
In the last 1 month, Fredun Pharma stock has moved down by -14.9%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 49.48% to 49.45% in Sep 2025 quarter
| Organisation | Fredun Pharmaceuticals Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Daulat N Medhora |
| E-voting on shares | Click here to vote |
Fredun Pharma share price today stands at ₹1440 as on at the close of the market. Fredun Pharma share today touched a day high of ₹1499.7 and a low of ₹1430.
Fredun Pharma touched a 52 week high of ₹1999 and a 52 week low of ₹635. Fredun Pharma share price today i.e. is closed at ₹1440, which is -27.96% down from its 52 week high and 126.77% up from its 52 week low.
Fredun Pharma market capitalisation is ₹793.66 Cr as on .
To buy Fredun Pharma shares, you need to follow these steps:
Fredun Pharma trading volume is 13.39K as on . This means that 13.39K shares of Fredun Pharma were bought and sold on the stock market during today's trading session.